Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Prescribing and dispensing patterns of asthma medications among children on the Navajo Nation.
The journal of allergy and clinical immunology. In practice·2026
Same author
Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.
Nature communications·2026
Same author
Serum Levels and Genetic Variants of CC16: Associations With Asthma and Lung Function Development.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author
Barriers to Implementation of SMART: Views From Pediatric Asthma Specialists.
Pediatric pulmonology·2025
Same author
The role of CC16 in the associations of preterm birth with lung function and asthma in adult life.
The Journal of allergy and clinical immunology·2025
Same author
No exposure left behind: time to pay attention to children's chemical environment in lung development.
The European respiratory journal·2025
Same journal
Asthma diagnosis in adults and children: challenges, future directions, and a call to action.
The Lancet. Respiratory medicine·2026
Same journal
The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children.
The Lancet. Respiratory medicine·2026
Same journal
Intensive care in global conflicts: brace for impact.
The Lancet. Respiratory medicine·2026
Same journal
PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study.
The Lancet. Respiratory medicine·2026
Same journal
RSV vaccination and immunisation programmes accelerating worldwide.
The Lancet. Respiratory medicine·2026
Related Experiment Video
Updated: May 4, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
10.7K
Does COPD begin in childhood?
Stefano Guerra1, Debra A Stern2, Wayne J Morgan3
1Arizona Respiratory Center, University of Arizona, Tucson, AZ 85724, USA; Centre for Research in Environmental Epidemiology, IMIM-Hospital del Mar, CIBERESP, Barcelona, Spain.
The Lancet. Respiratory Medicine
|January 17, 2014
Summary
No abstract available in PubMed .
